Members of the Department of Medicine are working to synthesize rapidly accumulating information about the treatment of hospitalized patients with COVID-19.
Celiac Disease Program
Charles River Plaza
165 Cambridge Street, 9th Floor
Boston, MA 02114
Hours: Monday–Friday, 8:00 am–5:00 pm
Services also available at:
Mass General North Shore Center for Outpatient Care
102-104 Endicott Street
Danvers, MA 01923
Explore This Program
A Multidisciplinary Approach to Care
The prevalence of celiac disease in the U.S. has quadrupled over the past 50 years. The Celiac Disease Program at Mass General brings together an expert team of providers who work with patients with celiac disease to co-create health.
This multi-disciplinary care team is tailored to each patient’s unique condition. Our providers include:
- GI pathologists
- GI radiologists
- Food allergy specialists
We offer the full range of endoscopic diagnostic procedures critical for obtaining a tissue diagnosis and differentiating celiac disease from other disorders such as inflammatory bowel disease (Crohn's disease and ulcerative colitis), microscopic colitis (lymphocytic and collagenous), eosinophilic and autoimmune enteritis, and irritable bowel syndrome (IBS).
Patient Education and Support
Patient education and support are important components of our mission. We are committed to helping patients understand their disease, assess their treatment options, participate in their treatment decisions and feel in control of their disease. Our physicians are experienced in fine-tuning medical therapies and helping patients obtain relief from persistent, difficult-to-manage symptoms.
To help educate the community about how our diet, lifestyle and environment can affect GI health, our doctors participate in community events throughout the year.
Advancing an Understanding of Celiac Disease through Ongoing Research
The Celiac Disease Program at Mass General is a comprehensive program dedicated to the diagnosis and treatment of patients with celiac disease and all gluten-mediated disorders. The gastroenterology department at Massachusetts General Hospital is consistently ranked among the nation's top programs, with Magnet award-winning nurses providing patients with compassionate, timely care. Magnet designation represents the highest honor available for nursing excellence and is achieved by fewer than 7% of hospitals in the United States. Our multidisciplinary team of providers has been recognized both nationally and internationally for groundbreaking research and outstanding patient care.
We believe that each patient can significantly improve our knowledge of celiac disease and contribute toward understanding the factors that influence the development of this disease and factors that determine response to treatments. All of the physicians involved in the Celiac Disease Program actively participate in research programs aimed at understanding the underlying cause of celiac disease, with the goal of developing more effective treatment approaches.
Dr. Ramnik Xavier, Chief of Gastroenterology, directs a research program that focuses on understanding the genetic basis of celiac disease based on genome-wide association studies. Dr. Xavier's research group actively collaborates with the lab of Dr. Cisca Wijmenga, a world leader in the genetics of celiac disease. In addition, Dr. Xavier works closely with Dr. Bana Jabri, a renowned immunologist who is working with Dr. Xavier to develop systems biology approaches to understanding the fundamental mechanisms underlying celiac disease.
Dr. John Garber III conducts a research program in intestinal epithelial biology with the goal of understanding factors that regulate the intestinal barrier both in the healthy state as well as in the setting of diseases such as celiac and inflammatory bowel disease. The integrity of the intestinal barrier is determined primarily by intercellular junctions, which also represent one of the primary pathways by which gluten gains access to the immune system. Despite the critical importance of intestinal junctions as a determinant of epithelial function, relatively little is known about the fundamental mechanisms that control the stability and responsiveness of junctions. Our lab is actively investigating the cellular constituents and mechanisms that function in intestinal junction assembly and turnover.
- Patient Story
- Mar | 31 | 2020
For the first 4.5 months of his life, Ethan stayed in the Neonatal Intensive Care Unit (NICU) at MassGeneral Hospital for Children (MGHfC), as many premature babies do. Initially, he could breathe on his own, but was intubated a few days after birth so his underdeveloped lungs could rest and grow
- Mar | 4 | 2020
Affirming similar results to the general population, researchers at Massachusetts General Hospital have shown that chronic prolonged hyponatremia is a risk factor for hip fracture in patients over age 60 who have chronic kidney disease.
- Press Release
- Feb | 11 | 2020
Researchers at Massachusetts General Hospital have uncovered a novel potential antiviral drug target that could lead to treatments protecting against a host of infectious diseases.
- Patient Story
- Jan | 31 | 2020
Colleen had suffered from worsening heartburn and laryngitis for years. She began to suspect there was a correlation between her worsening laryngitis and her heartburn and knew she needed to find answers and a permanent resolution.
- Press Release
- Dec | 12 | 2019
Study helps doctors recognize risk factors, symptoms of underdiagnosed food avoidance/restriction disorder
Study helps doctors recognize the symptoms and risk factors for avoidant/restrictive food intake disorder (ARFID) in adults so patients can be properly diagnosed and get help.